Keyword Analysis & Research: amgen pipeline


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
amgen pipeline1.240.16353914
amgen0.010.34731745
pipeline1.640.68356598

Keyword Research: People who searched amgen pipeline also searched

Keyword CPC PCC Volume Score
amgen pipeline1.780.4797724
amgen pipeline 20230.450.7637643
amgen pipeline oncology0.450.634242
amgen pipeline pdf1.930.8285466
amgen pipeline 20221.80.5308864
amgen pipeline drugs1.090.617374
amgen pipeline 20211.560.7325466
amgen pipeline products1.750.184837
amgen pipeline strengths10.6863027
amgen obesity pipeline0.610.8791015
amgen biosimilar pipeline1.240.5297157
amgen inc pipeline1.170.8221159
amgen drug pipeline0.890.3542959
amgen clinical pipeline0.840.4743463

Search Results related to amgen pipeline on Search Engine

  • Amgen Pipeline

    amgenpipeline.com

    https://www.amgenpipeline.com/

    WEBAmgen Pipeline. A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used to strengthen the evidence base of as many of our programs as possible.

    DA: 82 PA: 41 MOZ Rank: 99

  • Quarterly Amgen Pipeline Updates

    amgenpipeline.com

    https://www.amgenpipeline.com/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/PDF/amgen-pipeline-chart.pdf

    WEBAmgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market, returning to strategic partners, being outlicensed, or failing in clinical trials to demonstrate efficacy, safety or to deliver

    DA: 78 PA: 14 MOZ Rank: 60

  • AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE …

    amgen.com

    https://www.amgen.com/newsroom/press-releases/2023/10/amgen-to-present-new-research-from-oncology-portfolio-and-pipeline-at-esmo-2023

    WEBTHOUSAND OAKS, Calif., Oct. 16, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new data across its broad oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2023, taking place from October 20-24 in Madrid.

    DA: 72 PA: 20 MOZ Rank: 91

  • Amgen’s Latest Acquisition Puts a Spotlight on Rare Autoimmune …

    amgen.com

    https://www.amgen.com/stories/2022/11/amgens-latest-acquisition-puts-a-spotlight-on-rare-autoimmune-disease

    WEBNov 10, 2022 · The recent close of Amgen’s acquisition of ChemoCentryx, Inc. means that the medicine TAVNEOS has become the newest addition to Amgen’s broad and growing portfolio for inflammatory diseases. TAVNEOS (avacopan) is a medicine approved by the FDA as an adjunctive treatment for adults with severe active antineutrophil cytoplasmic …

    DA: 27 PA: 80 MOZ Rank: 15

  • AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL …

    amgen.com

    https://www.amgen.com/newsroom/press-releases/2023/06/amgen-presents-new-scientific-and-clinical-research-across-its-diverse-oncology-portfolio-and-pipeline-at-asco-2023

    WEBTHOUSAND OAKS, Calif., June 1, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new scientific and clinical research across its diverse oncology portfolio and pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from June 2-6 in Chicago.

    DA: 17 PA: 20 MOZ Rank: 73

  • NEW DATA SHOWCASES HOW AMGEN IS ADVANCING ALL …

    amgen.com

    https://www.amgen.com/newsroom/press-releases/2022/05/new-data-showcases-how-amgen-is-advancing-all-angles-of-cancer-care-through-innovative-oncology-portfolio-and-pipeline-at-asco-2022

    WEBTHOUSAND OAKS, Calif., May 26, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present new data from across its broad oncology innovative medicines and biosimilars portfolio and robust pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting from June 3-7 in Chicago and virtually.

    DA: 89 PA: 10 MOZ Rank: 69

  • Amgen: The Giant With An Impressive Pipeline - Seeking Alpha

    seekingalpha.com

    https://seekingalpha.com/article/4683743-amgen-the-giant-with-an-impressive-pipeline

    WEBApr 15, 2024 · The company has key pipeline milestones in 2024, focusing on expanding sales of rare disease drugs and advancing drugs in oncology. Despite strong financial results in FY'23, Amgen's...

    DA: 94 PA: 78 MOZ Rank: 43

  • Amgen's Investigational Targeted Treatment Bemarituzumab Granted

    amgen.com

    https://www.amgen.com/newsroom/press-releases/2021/04/amgens-investigational-targeted-treatment-bemarituzumab-granted-breakthrough-therapy-designation

    WEBApr 19, 2021 · THOUSAND OAKS, Calif., April 19, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for investigational bemarituzumab as first-line treatment for patients with fibroblast growth factor receptor 2b (FGFR2b) overexpressing …

    DA: 28 PA: 66 MOZ Rank: 71

  • Biosimilar Pipeline | Amgen Biosimilars

    amgenbiosimilars.com

    https://www.amgenbiosimilars.com/products/our-pipeline

    WEBAmgen has multiple drugs in the biosimilar pipeline across therapeutic areas, including immunology and oncology. Learn about our biosimilars in development.

    DA: 12 PA: 37 MOZ Rank: 6

  • Amgen's cancer-drug pipeline looks promising despite FDA …

    morningstar.com

    https://www.morningstar.com/news/marketwatch/20231011160/amgens-cancer-drug-pipeline-looks-promising-despite-fda-setback-analysts-say

    WEBOct 11, 2023 · Amgen Inc.'s (AMGN) pipeline of cancer, obesity and cardiovascular drugs is poised to deliver good news for the stock, analysts say, despite the company's recent setback with cancer drug...

    DA: 74 PA: 8 MOZ Rank: 10